Liver transplantation under the COVID-19
10.3760/cma.j.cn113884-20230317-00080
- VernacularTitle:肝移植与新型冠状病毒感染
- Author:
Ying XU
1
;
Dongdong LIN
Author Information
1. 首都医科大学附属北京佑安医院，北京 100069
- Keywords:
SARS-CoV-2;
Liver transplantation;
Organ donation
- From:
Chinese Journal of Hepatobiliary Surgery
2023;29(7):548-552
- CountryChina
- Language:Chinese
-
Abstract:
Novel coronavirus infection (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since 2019, the disease has spread worldwide and has become a public health epidemic of international concern. In 2022, the infection of SARS-CoV-2 variant Omicron reached its peak, posing a huge challenge to organ donation and transplantation. Organ transplant recipients have a high risk of immunosuppression and face with high risk of SARS-CoV-2 infection. There are some particularities in the diagnosis and treatment of COVID-19 in organ transplant recipients. This article reviewed the diagnosis and treatment of COVID-19 in liver transplantation recipients, and the progression of liver donation under the COVID-19.
